Design of cyclic peptides with agonist activity at melanocortin receptor-4

Bioorg Med Chem Lett. 2006 Jul 15;16(14):3723-6. doi: 10.1016/j.bmcl.2006.04.050. Epub 2006 May 5.

Abstract

A series of cyclic pentapeptides, c(His-D-Phe-Arg-Trp-Z) (Z=omega-amino acid), were prepared and biologically evaluated. The effects of increasing alkyl chain length of omega-amino acid on the functional activities and the receptor binding affinities for human melanocortin receptors (hMC-Rs) were studied. Compound 2 was an agonist for hMC-4R with an EC50 value of 15.4 nM, which was 4.7 times more potent than that of alpha-MSH. Compound 2 also showed a 4.3-fold higher hMC-4R selectivity over hMC-1R, thus providing us with information concerning size and chemical structure of the lactam ring for the development of the agonist with hMC-4R selectivity.

MeSH terms

  • Amino Acid Sequence
  • Circular Dichroism
  • Drug Design
  • Humans
  • Lactams / chemistry
  • Lactams / pharmacology
  • Molecular Sequence Data
  • Peptides, Cyclic / chemical synthesis*
  • Peptides, Cyclic / pharmacology*
  • Protein Binding
  • Receptor, Melanocortin, Type 1 / agonists
  • Receptor, Melanocortin, Type 1 / metabolism
  • Receptor, Melanocortin, Type 4 / agonists*
  • Receptor, Melanocortin, Type 4 / metabolism
  • Structure-Activity Relationship
  • alpha-MSH / metabolism

Substances

  • Lactams
  • Peptides, Cyclic
  • Receptor, Melanocortin, Type 1
  • Receptor, Melanocortin, Type 4
  • alpha-MSH